Regen BioPharma Inc (RGBP)

[Bridget21]

"On March 17,2022 the Company defaulted by failing to make the required payment and the Note Payable was reclassified as a convertible note as of that date. As of March 17th 2022 a penalty amount of $300,000 was added to the principal of the Note pursuant to the terms and conditions of the Note. As of March 31, 2022 the principal amount of $1,751,580 remains outstanding."